Kevin Beja

3.2k total citations · 1 hit paper
25 papers, 1.7k citations indexed

About

Kevin Beja is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Kevin Beja has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Kevin Beja's work include Prostate Cancer Treatment and Research (19 papers), Cancer Genomics and Diagnostics (17 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Kevin Beja is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Cancer Genomics and Diagnostics (17 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Kevin Beja collaborates with scholars based in Canada, Finland and United States. Kevin Beja's co-authors include Alexander W. Wyatt, Matti Annala, Kim N., Matti Nykter, Martin Gleave, Evan W. Warner, Gillian Vandekerkhove, Daniel Khalaf, Arun Azad and Colin C. Collins and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kevin Beja

25 papers receiving 1.7k citations

Hit Papers

Circulating Tumor DNA Genomics Correlate with Resistance ... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
    2018 347 citations Matti Annala, Gillian Vandekerkhove et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Beja Canada 16 1.4k 1.0k 552 545 157 25 1.7k
Evan W. Warner Canada 10 1.0k 0.8× 672 0.7× 342 0.6× 388 0.7× 136 0.9× 19 1.2k
Jianchun Duan China 23 1.1k 0.8× 673 0.7× 511 0.9× 1.0k 1.8× 82 0.5× 96 1.7k
Mateus Crespo United Kingdom 17 525 0.4× 393 0.4× 399 0.7× 421 0.8× 97 0.6× 44 1.0k
I. Wistuba United States 3 1.7k 1.3× 422 0.4× 589 1.1× 1.4k 2.5× 89 0.6× 6 2.0k
K.N. Chi Canada 17 1.2k 0.9× 405 0.4× 397 0.7× 703 1.3× 462 2.9× 76 1.6k
Adam Jendrisak United States 10 679 0.5× 518 0.5× 255 0.5× 510 0.9× 104 0.7× 32 988
Penelope Flohr United Kingdom 10 771 0.6× 555 0.5× 439 0.8× 302 0.6× 89 0.6× 25 1.1k
John L. Silberstein United States 12 728 0.5× 323 0.3× 314 0.6× 413 0.8× 126 0.8× 16 1.0k
Sandra E. Edwards United Kingdom 12 653 0.5× 430 0.4× 690 1.3× 307 0.6× 62 0.4× 15 1.2k
Wendy Onstenk Netherlands 19 397 0.3× 456 0.4× 257 0.5× 455 0.8× 86 0.5× 25 813

Countries citing papers authored by Kevin Beja

Since Specialization
Citations

This map shows the geographic impact of Kevin Beja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Beja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Beja more than expected).

Fields of papers citing papers by Kevin Beja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Beja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Beja. The network helps show where Kevin Beja may publish in the future.

Co-authorship network of co-authors of Kevin Beja

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Beja. A scholar is included among the top collaborators of Kevin Beja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Beja. Kevin Beja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumiyoshi, Takayuki, Xiaofei Wang, Evan W. Warner, et al.. (2023). Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. JNCI Journal of the National Cancer Institute. 116(1). 115–126. 2 indexed citations
2.
Annala, Matti, Sinja Taavitsainen, Daniel Khalaf, et al.. (2021). Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition. Clinical Cancer Research. 27(16). 4610–4623. 52 indexed citations
3.
Warner, Evan W., Cameron Herberts, Simon Fu, et al.. (2021). BRCA2 , ATM , and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression. Clinical Cancer Research. 27(6). 1650–1662. 52 indexed citations
4.
Warner, Evan W., Steven Yip, Matti Annala, et al.. (2020). Abstract PR09: Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations. Clinical Cancer Research. 26(11_Supplement). PR09–PR09. 1 indexed citations
5.
Syrzycka, Monika, Kathleen A Fitzpatrick, In Ho Kim, et al.. (2019). Genetic and Molecular Analysis of Essential Genes in Centromeric Heterochromatin of the Left Arm of Chromosome 3 inDrosophila melanogaster. G3 Genes Genomes Genetics. 9(5). 1581–1595. 6 indexed citations
6.
Vandekerkhove, Gillian, Werner J. Struss, Matti Annala, et al.. (2019). Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. European Urology. 75(4). 667–675. 134 indexed citations
7.
Annala, Matti, Gillian Vandekerkhove, Daniel Khalaf, et al.. (2018). Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer. Cancer Discovery. 8(4). 444–457. 347 indexed citations breakdown →
8.
Annala, Matti, Sinja Taavitsainen, Gillian Vandekerkhove, et al.. (2018). Frequent mutation of the FOXA1 untranslated region in prostate cancer. Communications Biology. 1(1). 122–122. 18 indexed citations
9.
Lee, Jeong Hyun, Xiaoyan Deng, Simon P. Duffy, et al.. (2018). Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissection. Lab on a Chip. 18(12). 1736–1749. 26 indexed citations
10.
Beltran, Himisha, Alexander W. Wyatt, Edmund C.P. Chedgy, et al.. (2017). Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy. Clinical Cancer Research. 23(22). 6802–6811. 52 indexed citations
11.
Vandekerkhove, Gillian, Tilman Todenhöfer, Matti Annala, et al.. (2017). Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer. Clinical Cancer Research. 23(21). 6487–6497. 122 indexed citations
12.
Annala, Matti, Werner J. Struss, Evan W. Warner, et al.. (2017). Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer. European Urology. 72(1). 34–42. 169 indexed citations
13.
Struss, Werner J., Matti Annala, Evan W. Warner, et al.. (2017). Germline DNA repair mutations in metastatic castration-resistant prostate cancer: Therapy response and applicability of circulating tumor DNA.. Journal of Clinical Oncology. 35(6_suppl). 140–140. 2 indexed citations
14.
Khalaf, Daniel, Matti Annala, Kevin Beja, et al.. (2017). Circulating tumor DNA (ctDNA) and correlations with clinical prognostic factors in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(6_suppl). 186–186. 3 indexed citations
15.
N., Kim, Matti Annala, Katherine Sunderland, et al.. (2017). A randomized phase II cross-over study of abiraterone + prednisone (ABI) vs enzalutamide (ENZ) for patients (pts) with metastatic, castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(15_suppl). 5002–5002. 31 indexed citations
16.
Liu, Ta-Wei, Donald A. R. Sinclair, Samy Cecioni, et al.. (2016). Genome-wide chemical mapping of O-GlcNAcylated proteins in Drosophila melanogaster. Nature Chemical Biology. 13(2). 161–167. 32 indexed citations
17.
Wyatt, Alexander W., Arun Azad, Stanislav Volik, et al.. (2016). Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer. JAMA Oncology. 2(12). 1598–1598. 266 indexed citations
18.
Hach, Faraz, Iman Sarrafi, Robert H. Bell, et al.. (2016). SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA. Bioinformatics. 33(1). 26–34. 44 indexed citations
19.
20.
Chedgy, Edmund C.P., Matti Annala, Kevin Beja, et al.. (2015). Moving Toward Personalized Care: Liquid Biopsy Predicts Response to Cisplatin in an Unusual Case of BRCA2-Null Neuroendocrine Prostate Cancer. Clinical Genitourinary Cancer. 14(2). e233–e236. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evan W. Warner Breakdown of academic impact, for papers by Jianchun Duan Breakdown of academic impact, for papers by Mateus Crespo Breakdown of academic impact, for papers by I. Wistuba Breakdown of academic impact, for papers by K.N. Chi Breakdown of academic impact, for papers by Adam Jendrisak Breakdown of academic impact, for papers by Penelope Flohr Breakdown of academic impact, for papers by John L. Silberstein Breakdown of academic impact, for papers by Sandra E. Edwards Breakdown of academic impact, for papers by Wendy Onstenk
Rankless by CCL
2026